Asiatic Laboratories’ earnings per share (EPS) rose by nearly 12% year-on-year in the first quarter of the current fiscal year, supported by higher sales revenue and net profit.
The pharmaceutical and chemicals company disclosed the information through the Dhaka Stock Exchange (DSE) on Sunday (November 22).
According to the disclosure, the company’s EPS stood at Tk1.39 in the July-September quarter, up from Tk1.24 in the same period a year earlier. This represents an increase of Tk0.15 per share.
The company attributed the growth to higher net profit after tax, increased deferred tax income and rising sales revenue during the quarter.
It also said the expansion of its business through the introduction of new marketing territories helped boost sales in new regions, contributing to the overall improvement in earnings.
Meanwhile, the company’s net asset value per share (NAVPS) stood at Tk59.57 as of September 30.

